F.D.A. Approves Narcan for Over-the-Counter Sales
The nasal spray reverses opioid overdoses and public health officials hope that making it more widely available could save lives and reduce the nation’s high rates of drug fatalities.
Posted inDrug Abuse and Traffic Drugs (Pharmaceuticals) Drugstores Emergent BioSolutions Inc Food and Drug Administration Naloxone (Drug) Opioids and Opiates
Over-the-Counter Narcan Could Save More Lives. But Price and Stigma Are Obstacles
The Food and Drug Administration is expected this week to allow the overdose-reversal medication to be sold without a prescription, a step toward making it a common emergency tool.
Posted inDrugs (Pharmaceuticals) Drugstores Opioids and Opiates Shortages Suits and Litigation (Civil)
How an Opioid Settlement Hinders Patients’ Access to ADHD Medication and Other Drugs
An agreement between attorneys general and major drug distributors increased scrutiny on medications for A.D.H.D., addiction, anxiety and pain.
Posted inCardinal Health Inc Decisions and Verdicts Drug Abuse and Traffic Drugs (Pharmaceuticals) Georgia McKesson Corporation Opioids and Opiates Suits and Litigation (Civil)
Opioid Distributors Cleared of Liability to Georgia Families Ravaged by Addiction
The case illustrates the enormous challenges that victims of the opioid crisis have had in getting compensation from the pharmaceutical industry, despite its pledge of billions of dollars to state and local governments.